Home


Login | Forgot password?
September 3, 2010

02.06.2010
ESC 2010 Barcelona
BrainsGate attends the ESC 2010 in Barcelona read more
03.03.2010
ISC 2010 San Antonio, TX
BrainsGate attends the International Stroke Conference (ISC) 2010 in San Antonio, TX read more
18.01.2010
ANIM 2010 Bad Homburg, Germany
BrainsGate attends the German ANIM meeting for the first time read more
28.08.2009
World Innovation Summit
BrainsGate invited to speak at the third World Innovation Summit in Tel Aviv, September 14. read more
19.08.2009
Nordic Stroke 2009
BrainsGate sponsors the 15th Nordic Congress on Cerebrovascular Diseases, 19-22 August 2009, Helsinki, Finland read more
16.06.2009
BioMed 2009
BrainsGate attends the BioMed 2009 in Tel Aviv read more
26.05.2009
ESC 2009
BrainsGate attends the ESC 2009 in Stockholm read more
18.02.2009
BrainsGate at ASA 2009
BrainsGate's booth was bigger and better than last year read more
25.09.2008
BrainsGate launches ImpACT-24
ImpACT-24 is a randomized, sham-controlled, double blind study to test the safety and efficacy of BrainsGate's ISS for treatment of acute ischemic stroke victims in a 24 hour window read more
20.02.2008
AHA Stroke conference
BrainsGate launches its pivotal trial, ImpACT-24 in New Orleans read more
06.06.2007
BioMed 2007
BrainsGate attends BioMed 2007 in Tel-Aviv read more
29.05.2006
BioMed 2006
BrainsGate attends BioMed 2006 in Jerusalem read more
09.04.2006
Bio 2006
BrainsGate attends Bio 2006 in Chicago read more
16.02.2006
International Stroke meeting 2006
BrainsGate attended and presented a poster read more
January 18, 2010
ANIM 2010 Bad Homburg, Germany
BrainsGate attends the German ANIM meeting for the first time > full story
September 25, 2008
BrainsGate launches ImpACT-24
ImpACT-24 is a randomized, sham-controlled, double blind study to test the safety and efficacy of BrainsGate's ISS for treatment of acute ischemic stroke victims in a 24 hour window > full story